Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jun 30, 2016, 03:15 ET Merck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance

  - New partners are joining founding members Merck KGaA, Darmstadt, Germany, Illumina and Genea to support standardization of...


Jun 29, 2016, 17:15 ET Novartis PKC412 (midostaurin) pivotal data published in NEJM show 60% response rate in advanced systemic mastocytosis (SM)

 Novartis announced today that The New England Journal of Medicine (NEJM) published data for PKC412 (midostaurin) demonstrating an overall...


Jun 29, 2016, 17:14 ET FDA clears first test to detect specific genetic markers for certain antibiotic-resistant bacteria directly from clinical specimens

The U.S. Food and Drug Administration today cleared for marketing the Xpert Carba-R Assay, an infection control aid that tests patient specimens to...


Jun 29, 2016, 16:05 ET Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Adolescents with Sickle Cell Disease

 Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...


Jun 29, 2016, 15:38 ET Universal Cancer Vaccine Trial Highlights Hope for New Cancer Treatments

By August Patterson, Senior Staff Writer, Financial Press Media Group, Inc. BATON ROUGE, LA, June 29, 2016 /PRNewswire/ - Researchers at...


Jun 29, 2016, 14:35 ET Eisai Highlights its Strong Pipeline and Innovative Approach to R&D at Company's U.S. Scientific Day

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today held a Scientific Day to present its approach to global R&D and...


Jun 29, 2016, 11:11 ET IgY Max Increases Beneficial Flora, Improves Gut Integrity

 A new study finds that IgY Max™ (i26®) improves gastrointestinal integrity by increasing beneficial flora, reducing inflammation in...


Jun 29, 2016, 09:35 ET Value-to-serve Business Model Spurs Growth Opportunities for Neuromodulation OEMs

 To sustain profits in existing end-user markets, original equipment manufacturers (OEMs) of neuromodulation medical devices need to adopt a...


Jun 29, 2016, 08:23 ET Biostage Files for FDA Orphan Drug Designation for Cellspan™ Esophageal Implant

 Biostage, Inc. (Nasdaq: BSTG), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening...


Jun 29, 2016, 08:00 ET BioPharmX Announces Positive Topline Phase 2a Clinical Trial Results for BPX-01 in Patients with Acne-Causing Bacteria

BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced topline...


Jun 29, 2016, 07:50 ET Echo Therapeutics Begins Testing of NextGen CGM System Components

 Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated...


Jun 29, 2016, 07:35 ET Ibrutinib (IMBRUVICA®) Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for the Development of a Treatment for Chronic Graft-Versus-Host Disease (cGVHD)

The U.S. Food and Drug Administration (FDA) has granted a fourth Breakthrough Therapy Designation (BTD) for ibrutinib (IMBRUVICA®): as...


Jun 29, 2016, 07:00 ET Shire Announces Positive Topline Results of SHP465 Efficacy and Safety Study in Adults With ADHD

- Topline results revealed the study met its primary endpoints for both doses of SHP465 (12.5mg and 37.5mg) administered once daily,...


Jun 29, 2016, 07:00 ET Center Point Clinical Services Signs Partnership Agreement with ContraVir Pharmaceuticals

Center Point Clinical Services, provider of specialty clinical research solutions including the signature Clinical Trials Research Pharmacist...


Jun 29, 2016, 06:30 ET Oncolytics Biotech® Inc. Announces Phase 2 Study in Female Patients with Colorectal Cancer Metastatic to the Liver

CALGARY, June 29, 2016 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX: ONC) (OTCQX: ONCYF) (FRA: ONY) today announced...


Jun 28, 2016, 18:22 ET FDA Advisory Committee recommends approval of Jardiance® (empagliflozin) for cardiovascular indication in 12-11 vote

A U.S. Food and Drug Administration (FDA) Advisory Committee today voted 12-11 that substantial evidence exists to establish that Jardiance®...


Jun 28, 2016, 13:24 ET OmniSeq Receives New York CLEP Approval For 144 Gene Comprehensive Panel And Partners With Cure Forward To Advance Precision Medicine For Cancer Patients

 OmniSeq, a subsidiary of Roswell Park Cancer Institute, received New York State Clinical Laboratory Evaluation Program (CLEP) approval for...


Jun 28, 2016, 13:12 ET ClariMem® Health announces: Top Ivy League Researchers create Compound that Restores Crucial Brain Function in Older Adults in just 12 Weeks

ClariMem® Health, Inc., announced that its lead formula ClariMem® with L-TAMS was featured in the "Fighting Alzheimer's" section of USA...


Jun 28, 2016, 12:22 ET BeyondSpring's Global Phase III Non-Small Cell Lung Cancer Clinical Trial for Plinabulin Launches in China

 BeyondSpring Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, including...


Jun 28, 2016, 11:45 ET Nova opção de tratamento da Novartis para DPOC reduz o número de crises e melhora a função pulmonar

A Novartis anuncia a publicação do estudo FLAME no New England Journal of Medicine, pesquisa que compara a eficácia de Ultibro®...